Finland· FI-REL-REL64202
LYROKAUL
A lerodalcibep product containing lerodalcibep, registered in Finland by LIB Therapeutics B.V.. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Lerodalcibep is registered in 2 of 19 countries.
Countries holding a registration under ATC C10AX19 (lerodalcibep), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Lerodalcibep · ATC C10AX19
2 / 19 countries
- Finlandprice
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Lerodalcibep
- Manufacturer
- LIB Therapeutics B.V.
- Country
- Finland (FI)
- ATC code
- C10AX19
- ATC class
- Lerodalcibep
- Defined daily dose
- 4.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lerodalcibep in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c0d9b0a1-7a32-4d5e-8a42-08c0d67bf8b3 GET /v1/drugs/c0d9b0a1-7a32-4d5e-8a42-08c0d67bf8b3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, liuos, esitäytetty ruisku",
"route": "Ihon alle",
"ddd_unit": null,
"strength": "300 mg",
"atc_label": "lerodalsibepi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/26/2061/001",
"fimea_rel_id": "REL64202",
"authorised_at": "2026-09-18"
}See everything about lerodalcibep.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.